β-arrestin-2 is involved in irisin induced glucose metabolism in type 2 diabetes via p38 MAPK signaling
Authors:
- 1 November 2017
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 360 (2) , 199-204
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Circulating serum irisin levels in obesity and type 2 diabetes mellitusIUBMB Life, 2016
- SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjectsLipids in Health and Disease, 2016
- Determinants of mortality in patients with type 2 diabetes: a reviewReviews in Endocrine and Metabolic Disorders, 2016
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2015
- Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase SignalingDiabetes, 2014
- The Structure of Irisin Reveals a Novel Intersubunit β-Sheet Fibronectin Type III (FNIII) DimerJournal of Biological Chemistry, 2013
- Irisin and FNDC5 in retrospectAdipocyte, 2013
- Serum irisin levels in new-onset type 2 diabetesDiabetes Research and Clinical Practice, 2013
- Pathomechanisms of Type 2 Diabetes GenesEndocrine Reviews, 2009
- β-Arrestins: Multifunctional Cellular MediatorsPhysiology, 2008